CD8A and neoplasm: In addition, decreased abundance of TNFRSF1B in CD8+ T cells in the tumour and spleen, indicating that anti‐TNFRSF1B antibody treatment could reduce the suppressed CD8+TNFRSF1B+ T cells (Figure 6E,H).